MedPath

NEOLOID EML 36.4%

NEOLOID EML 36.4%

Discontinued
DIN Number

02066971

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

bradley pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02066971
AIG Number0106991007
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A06AB05 CASTOR OIL
Product Specifications
Dosage FormEmulsion
Route of AdministrationOral
AHFS Classification56:12.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CASTOR OILActive
Strength: 36.4 %
Monograph: CASTOR OIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.